Behzad Rahimi

Behzad Rahimi

Auto-generated profile, based on publicly available information

Behzad Rahimi

Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2016 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
YRYOUSEF REZAEI
YOUSEF REZAEI
KKKamal Khademvatani
Kamal Khademvatani
BRBehzad Rahimi
Behzad Rahimi
MKMehran Khoshfetrat
Mehran Khoshfetrat
NANasim Arjmand
Nasim Arjmand
MSMir‐Hossein Seyyed‐Mohammadzad
Mir‐Hossein Seyyed‐Mohammadzad
Background: Contrast medium–induced acute kidney injury ( CIAKI ) is a leading cause of acquired renal impairment. The effects of antioxidants have been conflicting regarding the prevention of CIAKI . We performed a study of vitamin E use to decrease CIAKI in patients undergoing elective coronary angiography. Methods and Results: In a placebo‐controlled randomized trial at 2 centers in Iran, 300 patients with chronic kidney disease—defined as estimated glomerular filtration rate <60 mL/min per 1.73 m 2 —were randomized 1:1 to receive 0.9% saline infusion 12 hours prior to and after intervention combined with 600 mg vitamin E 12 hours before plus 400 mg vitamin E 2 hours before coronary angiography or to receive placebo. The primary end point was the development of CIAKI, defined as an increase ≥0.5 mg/dL or ≥25% in serum creatinine that peaked within 72 hours. Based on an intention‐to‐treat analysis, CIAKI developed in 10 (6.7%) and 21 (14.1%) patients in the vitamin E and placebo groups, respectively ( P =0.037). Change in white blood cell count from baseline to peak value was greater in the vitamin E group compared with the placebo group (−500 [−1500 to 200] versus 100 [−900 to 600]×10 3 /mL , P =0.001). In multivariate analysis, vitamin E (odds ratio 0.408, 95% CI 0.170–0.982, P =0.045) and baseline Mehran score (odds ratio 1.257, 95% CI 1.007–1.569; P =0.043) predicted CIAKI. Conclusions: Prophylactic short‐term high‐dose vitamin E combined with 0.9% saline infusion is superior to placebo for prevention of CIAKI in patients undergoing elective coronary angiography. Clinical Trial Registration: URL : https://www.clinicaltrials.gov/ . Unique identifier: NCT 02070679.

26 November 2014
Verified
Journal Article
Closed access
MRMohammad Hossein Rahimi Rad
Mohammad Hossein Rahimi Rad
PRParvaneh Rahimi
Parvaneh Rahimi
BRBehzad Rahimi
Behzad Rahimi
MGMahdia Gholamnaghad
Mahdia Gholamnaghad

28 July 2020 in Iranian Red Crescent Medical Journal
Verified
Journal Article
Open access
PDF file
SFSamira Faraji
Samira Faraji
RZRasoul Zarrin
Rasoul Zarrin
AZAsma Zamanian
Asma Zamanian
RHReza Hajizadeh
Reza Hajizadeh
PAParvin Ayremlou
Parvin Ayremlou
BRBehzad Rahimi
Behzad Rahimi
Background: Hypertension is one of the most serious global concerns since it has affected over 1.2 billion people. Objectives: The present study aimed to determine the effect of vitamin D supplementation on blood pressure, fasting blood sugar, and lipid profile in hypertensive patients with vitamin D deficiency. Methods: In this double-blinded randomized placebo-controlled clinical trial study, 116 hypertensive patients (intervention and placebo groups, 58 each) with vitamin D deficiency (< 30 ng/mL with ECL) for 14 weeks, started from the beginning of autumn 2019 in Seyed-al-Shohada Educational Hospital in Urmia City. Fifty-five patients (49%) were male with the mean vitamin D 15.89 ± 5.09 ng/mL and 57 females with 17.29 ± 6.31 ng/mL. In a stratified blocked randomization scheme, the patients were randomly allocated into similar sized intervention and control groups based on body mass index (BMI), then the randomization with four block size was performed in each of strata by random allocation software. The intervention group received six doses of 50,000 IU vitamin D supplements for 6 weeks, then two supplements for two following months (one capsule per month). Blood pressure (24/h blood pressure measured by an ambulatory blood pressure monitoring device), vitamin D, FBS, and lipid profile (HDL, LDL, CL, and TG) were all measured at baseline and end of the study. Physical activity (measured by short IPAQ questionnaire), sun exposure using a questionnaire, dietary intake of vitamin D using three 24-hour recalls during the intervention, and anthropometric indices were measured at baseline, middle, and end of the study. Fifty-six patients in each group completed the study. The study was approved by the Ethics Committee of the Urmia University of Medical Sciences (ethics code: IR.UMSU.REC.1398.192). Results: The office blood pressure, 24-h systolic blood pressure (SBP) and diastolic blood pressure (DBP), nighttime SBP and DBP were significantly reduced in the intervention group compared to the control group, whereas the reduction of daytime SBP and DBP was not statistically significant. Vitamin D supplementation significantly decreased serum triglyceride, cholesterol, and LDL levels. Conclusions: Vitamin D supplementation had positive effects on blood pressure, triglyceride, cholesterol, and LDL levels in patients with low serum vitamin D. Keywords Vitamin D Hypertension Vitamin D Deficiency Ambulatory Blood Pressure Monitoring

1 December 2014
Verified
Journal Article
Open access
SHSaeed Oni Heris
Saeed Oni Heris
BRBehzad Rahimi
Behzad Rahimi
GFGholamreza Faridaalaee
Gholamreza Faridaalaee
MHMojgan Hajahmadi
Mojgan Hajahmadi
HSHojjat Sayyadi
Hojjat Sayyadi
BNBahman Naghipour
Bahman Naghipour
QT dispersion (QTd) is equal to longer QTc minus shorter QTc measured by 12-lead electrocardiogram (ECG). QTd reflects inhomogeneity in repolarization of ventricular myocardium and because of easy and fast measurement of QTd, it can be used to predict high-risk patients for dysrhythmia after Acute Myocardial Infarction (AMI). This study aimed to assess the effect of thrombolytic therapy on QTd before and 1 hour and 4 days after beginning of thrombolytic therapy. The patients with chest pain and ST Elevated Myocardial Infarction (STEMI) that underwent thrombolytic therapy were enrolled into this study. Streptokinase was the thrombolytic agent in all the patients. Standard 12-lead (ECG) was evaluated before beginning of thrombolytic therapy (QTd 1) and 1 hour (QTd2) and 4 days (QTd3) after thrombolytic therapy. First, ECG was magnified × 10 for exact calculation of QT and QTd. After all, the variables were compared using one–way analysis of variance (ANOVA). Besides, P ≤ 0.05 was considered as statistically significant. This study was conducted on 160 patients. The results revealed no significant differences among QTd 1, QTd 2, and QTd 3 (P > 0.05). At inferior AMI, however, a significant difference was observed among QTd1, QTd2, and QTd3 (P = 0.031). Thrombolytic therapy had no significant effects on QTd. Thus, thrombolytic therapy does not increase the risk of arrhythmia.

26 March 2024 in Turkish Journal of Vascular Surgery
Verified
Journal Article
Open access
PDF file
BABehnam Askari
Behnam Askari
BRBehzad Rahimi
Behzad Rahimi
SMSima Masudi
Sima Masudi
SMSirvan Mohammadian
Sirvan Mohammadian
KAKiana Askari
Kiana Askari
RHReza Hajizadeh
Reza Hajizadeh
Aim: Acute aortic dissection type A (AADA) is a life-threatening emergency with high mortality rates. Surgical intervention is the preferred and potentially life-saving treatment, but perioperative mortality remains a significant concern. Identifying the risk factors associated with surgical mortality, morbidity, and survival rates is essential. Therefore, this study aimed to characterize the preoperative and intraoperative risk factors for death during surgical repair of AADA.Material and Methods: We included 64 consecutive patients who underwent surgical repair between April 2013 and March 2021 in a tertiary heart center. Perioperative characteristics and variables were collected and analyzed to find any correlation between them and in-hospital Outcomes.Results: Aortic dissection surgery was performed on an average of 8 patients annually, accounting for approximately 1.7% (64/3757) of all open-heart surgery cases. The in-hospital mortality rate was 28% (18/64). The main predisposing factors for in-hospital death were cardiac failure (11.1%), stroke (16.7%), uncontrollable hemorrhage (27.8%), renal failure (11.1%), respiratory failure (11.1%), and postoperative multi-organ failure (22.2%). We found no associations between cardiopulmonary bypass duration and mortality. During the routine use of cerebral protective perfusion, we did not encounter any cases of coma. Left ventricular hypertrophy, a short distance of intimal tear to the aortic valve, and renal failure were associated with postoperative bleeding tendency.Conclusion: Our study showed that multiple factors such as heart failure, uncontrolled bleeding, and respiratory failure increase in-hospital mortality of patients with dissection of aorta type A, but duration of surgery does not have any association with in-hospital death.

1 February 2020 in Journal of Research in Clinical Medicine
Verified
Journal Article
Open access
PDF file
BRBehzad Rahimi
Behzad Rahimi
RHReza Hajizadeh
Reza Hajizadeh
ASAli Soleimany
Ali Soleimany
SGSara Ghiyasi
Sara Ghiyasi
HKHadiseh Kavandi
Hadiseh Kavandi
NONader Jangi Oskuei
Nader Jangi Oskuei
Objective: CAE characterized as diffuse dilatation of epicardial coronary arteries has been shown to have association with risks of death and myocardial infarction. Neutrophil count and neutrophil to lymphocyte ratio (NLR) are cost effective, available and rapidly measureable inflammatory marker. In this study we decided to investigate the association between these factors as inflammatory markers and CAE severity. Methods: In this cross sectional study 577 patients who underwent coronary angiography between September 2016 and September 2017 were evaluated. According to angiography findings patients were divided into four groups: 1-normal coronary artery, 2-coronary artery diseased group, 3-low risk coronary artery ectasia (CAE) and 4-high risk CAE. Results: In CAE group 61 patients (52.1%) had one vessel involvement and defined as low risk and 56 patients (47.9%) had two or more vessel involvement and grouped as high risk CAE. NLR was non-significantly higher in CAD group following high risk CAE group. (2.61±0.51 and 2.33±0.11 respectively) absolute neutrophil count was significantly higher in CAD and high risk CAE groups. Conclusion: Neutrophil count is an inflammatory marker with good association with coronary artery ectasia and coronary artery disease.